BFW was the first one to point this out 2 days back...and slide 21 says it all...this is already a kidney disease drug in the making!!!
Heck...any Big Pharma would be mad not to make a bid for RVX right away based on just slide 21. If cognitive data is half as impressive as slide 21, then the estimate of $4 billion that Don McCaffrey was supposedly talking about...is well within the realm of possibility.
Just from slide 21 and the safety data, I would have $2 billion as a starting bid for RVX...if I was a Big Pharma.
Iconoclast